Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study
- PMID: 20049227
- PMCID: PMC2800066
- DOI: 10.3390/ijerph6112822
Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study
Abstract
We assess the influence of co-occurring psychiatric disorders on retention in 189 opioid dependent patients in a methadone maintenance treatment (MMT) and determine the incidence of psychiatric co-morbidity during an 18-month follow-up period. About 68.5 % were retained in the MMT. Neither co-occurring mental disorders (chi-square = 0.303, df = 1, p = 0.622) nor methadone doses [85 (88.9) vs. 79.2 (85) mg/day, p = 0.672] were related to retention. In the follow-up period 19 new diagnoses were made, mainly major depression and antisocial and borderline personality disorders. Co-occurring psychiatric disorders should be assessed during MMT follow-up.
Keywords: co-occurring psychiatric disorders; incidence; methadone; retention.
Figures
Similar articles
-
Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.Am J Addict. 2016 Jan;25(1):49-55. doi: 10.1111/ajad.12317. Epub 2015 Dec 21. Am J Addict. 2016. PMID: 26692463
-
Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.Subst Abus. 2019;40(2):185-193. doi: 10.1080/08897077.2018.1547810. Epub 2019 Mar 19. Subst Abus. 2019. PMID: 30888262
-
Challenges and outcomes of parallel care for patients with co-occurring psychiatric disorder in methadone maintenance treatment.J Dual Diagn. 2014;10(2):60-7. doi: 10.1080/15504263.2014.906132. J Dual Diagn. 2014. PMID: 24976801 Free PMC article. Clinical Trial.
-
The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.Pharmacogenomics. 2018 Jun 1;19(8):741-747. doi: 10.2217/pgs-2018-0017. Epub 2018 May 22. Pharmacogenomics. 2018. PMID: 29785888
-
Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".J Med Toxicol. 2016 Mar;12(1):58-63. doi: 10.1007/s13181-015-0517-5. J Med Toxicol. 2016. PMID: 26567033 Free PMC article. Review.
Cited by
-
Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study.J Addict. 2016;2016:6487217. doi: 10.1155/2016/6487217. Epub 2016 Jan 21. J Addict. 2016. PMID: 26904355 Free PMC article.
-
The opioid crisis: past, present and future policy climate in Ontario, Canada.Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):45. doi: 10.1186/s13011-017-0130-5. Subst Abuse Treat Prev Policy. 2017. PMID: 29096653 Free PMC article.
-
Associations between happiness with social factors and opioid agonist therapy among people who inject drugs.Sci Rep. 2025 Apr 6;15(1):11790. doi: 10.1038/s41598-025-95967-y. Sci Rep. 2025. PMID: 40189642 Free PMC article.
-
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.Drug Alcohol Depend. 2021 Nov 1;228:108996. doi: 10.1016/j.drugalcdep.2021.108996. Epub 2021 Aug 28. Drug Alcohol Depend. 2021. PMID: 34555691 Free PMC article. Clinical Trial.
-
Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.Addiction. 2022 Jan;117(1):151-161. doi: 10.1111/add.15594. Epub 2021 Jun 22. Addiction. 2022. PMID: 34105213 Free PMC article. Clinical Trial.
References
-
- Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515–532. - PubMed
-
- Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat. 2005;28:321–329. - PubMed
-
- Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia DO, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100:981–989. - PubMed
-
- Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 1997;92:707–716. - PubMed
-
- Torrens M, Domingo-Salvany A, Alonso J, Castillo C, San L. Methadone and quality of life. Lancet. 1999;353:1101. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous